Precision Medicine Group, LLC
Precision Medicine Group, LLC, headquartered in the United States, is a leading entity in the life sciences industry, specialising in precision medicine and drug development. Founded in 2014, the company has rapidly established itself as a key player, offering a comprehensive suite of services that includes clinical trial management, regulatory consulting, and market access strategies. With a focus on personalised healthcare solutions, Precision Medicine Group leverages advanced analytics and innovative methodologies to enhance patient outcomes. Their unique approach integrates scientific expertise with operational excellence, setting them apart in a competitive market. The company has achieved significant milestones, including collaborations with major pharmaceutical firms and contributions to groundbreaking therapies, solidifying its reputation as a trusted partner in the evolving landscape of healthcare.
DitchCarbon Score
How does Precision Medicine Group, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Precision Medicine Group, LLC's score of 25 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Precision Medicine Group, LLC's reported carbon emissions
Precision Medicine Group, LLC, headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is committed to climate action, having established near-term targets as part of its sustainability initiatives. While no net-zero commitment has been made, Precision Medicine Group is actively engaged in reducing its carbon footprint within the pharmaceuticals, biotechnology, and life sciences sector. The company is classified as a current subsidiary, inheriting its sustainability initiatives from its parent organisation, Precision Medicine Group, LLC. As of January 2024, the company has committed to near-term reduction targets, although specific numerical goals have not been disclosed. This commitment reflects a growing trend within the industry to address climate change and reduce greenhouse gas emissions, aligning with broader corporate responsibility efforts. Overall, while specific emissions data is lacking, Precision Medicine Group's commitment to sustainability and climate action is evident through its established targets and initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Precision Medicine Group, LLC is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
